EUCTR2020-004285-19-IT进行中（未招募）1 期
A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19 - ACTIVE4-ACUTE
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •= 18 years of age
- •Hospitalized for COVID-19*
- •Enrolled within 72 hours of hospital admittance or 72 hours of positive COVID test
- •Expected to require hospitalization for > 72 hours
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 2000
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 2000
排除标准
- •Imminent death
- •Requirement for chronic mechanical ventilation via tracheostomy prior to hospitalization
研究者
相似试验
进行中（未招募）
1 期
A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19EUCTR2020-004285-19-ESFundación para la investigación biomédica del Hospital Universitario La Paz3,000
招募中
3 期
STRIVE Appendix E1: S-217622 (Ensitrelvir)JPRN-jRCT2031220667Ohmagari Norio50
招募中
Unknown
A Multicenter, Adaptive, Randomized, Controlled Trial Platform To Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized Patients with Respiratory InfectionsCodes for special purposesKCT0008917Seoul National University Bundang Hospital50
招募中
1 期
A Multicenter, Adaptive, Randomized, Controlled Trial Platform to Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized Patients with Respiratory Infections: Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE) - Shionogi Protease Inhibitor (S-217622)COVID-19MedDRA version: 23.0Level: PTClassification code: 10084268Term: COVID-19 Class: 100000004862CTIS2022-501020-19-01niversity Of Minnesota1,520
招募中
1 期
A Multicenter, Adaptive, Randomized, Controlled Trial Platform to Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized Patients with Respiratory Infections: Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE) - Immune Modulation Strategy TrialCOVID-19MedDRA version: 23.0Level: PTClassification code: 10084268Term: COVID-19 Class: 100000004862CTIS2023-504487-41-00niversity Of Minnesota1,520